Jacob Litke
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2020First federal award
$3.7MFederal grants as PI8 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
8 awards · $3.7M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jan 22, 2025 | NIH | SBIR Phase I Synthetic biology approaches for bio-orthogonal labeling of circular RNAs | $303K | CHIMERNA THERAPEUTICS, INC. |
| Aug 28, 2024 | NIH | SBIR Phase II Next-generation RNA synthesis and labeling kits | $311K | CHIMERNA THERAPEUTICS, INC. |
| Sep 13, 2023 | NIH | SBIR Phase II Next-generation RNA synthesis and labeling kits | $601K | CHIMERNA THERAPEUTICS, INC. |
| Sep 7, 2022 | NIH | SBIR Phase I A Novel TDP-43-Targeting Circular RNA to Treat Amyotrophic Lateral Sclerosis (ALS) | $256K | CHIMERNA THERAPEUTICS, INC. |
| Sep 1, 2022 | NIH | SBIR Phase II Next-generation RNA synthesis and labeling kits | $1.2M | CHIMERNA THERAPEUTICS, INC. |
| Aug 30, 2022 | NIH | SBIR Phase II Next-generation RNA synthesis and labeling kits | $586K | CHIMERNA THERAPEUTICS, INC. |
| Aug 1, 2020 | NIH | SBIR Phase I Using highly expressed circular RNAs to substantially enhance protein expression yields in mammalian cells | $225K | CHIMERNA THERAPEUTICS, INC. |
| Jul 31, 2020 | NIH | SBIR Phase I Using highly expressed circular RNAs to substantially enhance protein expression yields in mammalian cells | $225K | CHIMERNA THERAPEUTICS, INC. |
Peer ranks
Federal funding#446
Awards as PI#190
Patents#273
Companies
- CHIMERNA THERAPEUTICS, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.